Figure 4From: Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancerIn vitro cytotoxicity of Ad5MK. Pancreatic cancer cells were plated in triplicate in 12-well plates at 1.0 × 104 cells/well. After 24 to 36 h, the cells were infected with Ad5GFP or Ad5MK at various MOIs. After 1, 3, and 5 days, the number of viable cells was counted.Back to article page